FTC says ViroPharma abused FDA petitioning process
The Federal Trade Commission sued Shire ViroPharma yesterday for allegedly manipulating the Food and Drug Administration citizen petition process to keep its monopoly on a gastrointestinal infection medicine.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10